(4-(tert-Butoxy)phenyl)boronic acid, 95.0%, 250mg

1-Thien-2-ylcyclopropanecarboxylic acid, 97.0%, 250mg

(R)-2-Phenylpropan-1-amine, 95.0%, 25g

Phthalimidoacetaldehyde>98.0%(N)5g

(S)-2-Aminomethyl-1-N-Cbz-pyrrolidine, 95.0%, 5g

4-Iodopyridine, 97.0%, 10g

4-((5-Oxo-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidin-2-yl)amino)thiophene-2-carbonitrile, 97%, 100mg

2-Chloro-4-methylsulfanylpyrimidine, 95.0%, 25g

2-Bromo-5-hydroxypyridine>98.0%(GC)(T)5g

5-Hydroxy-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, 95%, 100mg

o-toluidina, mínimo 99,5 %, pa, 500 ml, envase de vidrio

(1-allyl-1H-benzimidazol-2-yl)methanol, 95.0%, 1g

6-Bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-one, 98%, 100mg